Philips shareholders appoint Roy Jakobs as next President and CEO
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
The company will address the observations within a stipulated timeline working with the regulators
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
Mirabegron Extended-Release Tablets, 25 mg and 50 mg, had estimated annual sales of US $2.4 billion in US
The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services
Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of US $64 million in the US
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
There is also a growing interest in whole generation sequencing (WGS)
He is a seasoned professional having worked in reputed corporates in API business with over 35+ years of experience covering manufacturing, general management, and business
Subscribe To Our Newsletter & Stay Updated